TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Acceleration time to ejection time ratio (At/Et) of fetal pulmonary artery Doppler
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: OME consumption at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute ischemic stroke (AIS) or transient ischemic attack (TIA) diagnosis at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Quality of Postoperative Analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Pulmonary Vascular Resistance (PVR) at 12 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from Baseline in 6-Minute Walk Distance (6MWD) at 12 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of post-traumatic stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Low anterior resection syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: cGRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MMP2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Allergic reaction (food challenge positive)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: No allergic reaction (food challenge negative)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum tryptase at timepoint 0
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Prevalence of the Wire Syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low frequency fatigue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Fatigue
Primary endpoint: Quality of life after ESSURE removal
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Area Under the Plasma Concentration-Time Profile (AUClast) for Ethinyl Estradiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Profile (AUClast) for Levonorgestrel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Maximum Plasma Concentration (Cmax) for Ethinyl Estradiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Maximum Plasma Concentration (Cmax) for Levonorgestrel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Liver decompensation requiring hospital admission
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with signs of brachial plexus injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: AUCt of CKD-386(5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of CKD-386(5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Motion sickness intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence or absence of a multidisciplinary treatment approach
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety as assessed by CTCAE
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Tolerated Dose (MTD) of Allogeneic CD4+ T cell Infusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Postprandial Metabolic Flexibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of high-grade Complete Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of symptomatic GERD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Performance of Continuous Glucose Monitoring System
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Pediatric Accommodation Scale, Parent-Report
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximum observed metformin plasma concentration at steady state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the metformin plasma concentration-time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed warfarin plasma concentration at steady state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the warfarin plasma concentration-time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed atorvastatin plasma concentration at steady state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number serious adverse events reported for all participants
Endpoint domain: Adverse events/effects
Primary endpoint: area under the plasma concentration-time curve from 0 to 72 hours (AUC0-72)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area under the plasma concentration-time curve from 0 to t hours (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Autism assessment index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clear image length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from atrial fibrillation and/or atrial tachycardia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: serum level of AFP-L3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum level of DCP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum level of Soluble PDGFRβ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numerical Pain Rating Scale Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Verbal Category Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numerical Rating Scale for Anxiety (VASA)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: efficiency of AI model in diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Current neck pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Mortality: proportion of participants alive
Endpoint domain: Mortality/survival
Primary endpoint: Effective face-down position time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to use CGM
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Staff's Perceived Competency of Hemiparesis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Staff's Actual Competency of Hemiparesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Staff's Actual Competency of Amadeo
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in functional ability of the treated shoulder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: device survivorship
Endpoint domain: Adverse events/effects
Primary endpoint: Male factors in male patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Two Minute Walking Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prosthetic Evaluation Questionnaire (PEQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Safety of F01 cells
Endpoint domain: Adverse events/effects
Primary endpoint: Antitumor activity of SLC-391 (objective response rate [ORR])
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in quality-adjusted life expectancy
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Concordance of protein intake estimation methods
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Feasibility of measuring trigeminal somatosensory evoked potentials
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient preference for blood-based screening
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of the mHealth component
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of the in-person skills development workshop
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reach of the coaching calls and optional email listserv
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean change in daily number of loose stools
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Radiographic bone level changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Maximum Plasma concentration of radiprodil (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetic plasma concentration of radiprodil: half-life (T1/2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in mean daytime SBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Score of Depressive Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 12-month Progression Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Willingness to accept donor organs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Geometric Mean Titer (GMT) of Neutralizing Antibody against RSV-serotype A
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric Mean Concentration (GMC) of RSV-Prefusion F protein specific IgG Antibody against RSV-serotype A
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Persistent Post Concussive Symptoms (PPCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Days until Recovery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Child Screen Media Use (Time)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Child Screen Media Use (Proportion Educational)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Target concentration at first steady-state concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects who comply with the research protocol
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of persons with GD identified
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of previously undiagnosed persons testing positive for GD
Endpoint domain: Mortality/survival
Primary endpoint: Persistent Opioid Use
Endpoint domain: Adverse events/effects
Primary endpoint: Uptake of HPV Vaccination
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Uptake of HPV Self-collection
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: effectiveness of Neuromodulation techniques
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Freedom from Atrial Fibrillation/Atrial Flutter/Atrial Tachycardia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Lower artery or bypass graft thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Changes in nutritional intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in fractional excretion of lithium (FELi)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Tubular diuretic efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Composite score HRQoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Patient-experienced quality of healthcare
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline in patient reported knee pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Success rate on first intubation attempts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Unplanned 30-day readmission
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: GAF Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: BAM Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Bite force distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Surface EMG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survey
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in sleep duration measured by wearable device (mins)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: digital remote physiological data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Participants Who Login to the Portal
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of medications prescribed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Lipid Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Glucose Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Quick-DASH functional scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of respiratory infections and diseases in the previous 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Exacerbations in the previous 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Blood Eosinophil count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Risk of developing autoimmune thyroid disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Incidence of recurrence of perianal fistula
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Post-operative anastomotic leakages
Endpoint domain: Adverse events/effects
Primary endpoint: Amount of endogenous neuromodulation (difference in oscillatory power)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Activities of Daily Living (ADL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in estimated glomerular filtration rate (eGFR) values from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in albumin or protein excretion values from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Effectiveness outcome
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Breast milk metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Severity of treatment emergent adverse events (TEAE's)
Endpoint domain: Adverse events/effects
Primary endpoint: Score in the Perceived Cognitive Impairment (PCI) subscale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Kessler Psychological Distress Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Engagement length
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Geographic Atrophy lesion area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of XEN45
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pulse Oximetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Patient Consciousness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypnotic discontinuation rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Insomnia remission rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first Giant cell arteritis (GCA) clinical relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evidence of motor block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Cases Where Lymphatics Were Visualized
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Cases Where Lymphatics Were Spared
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Oxygen Saturation % by Pulse Oximetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency, types, severity and relationship to study drug of adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Time of recovery of work and life after surgery
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in symptomatology related to PIPJ OA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plantar ulcer recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of treatment-emergent hematologic side effects
Endpoint domain: Adverse events/effects
Primary endpoint: CleoDX adnexal mass score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety - change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mindful attention - change
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Jump-landing biomechanics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Adverse Events After CAR 20/19-T Cell Infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Adverse Events After Pirtobrutinib Administration in Part A
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Adverse Events After Pirtobrutinib Administration in Part B
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in plasma HIV-1 ribonucleic acid (RNA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants experiencing ≥1 adverse event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants discontinuing from study due to an AE
Endpoint domain: Adverse events/effects
Primary endpoint: Absence of moderate or severe pain at 2 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in Post-operative healing of septal perforation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra-rater reliability of ultrasonographic TMT measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inter-rater reliability of ultrasonographic TMT measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement of ultrasonographic TMT measurement with MRI and CT measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fitted Filtration Efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cranial Morphology- Self Evaluation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of intermetatarsal bursitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of Morton's neuroma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of other pathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient tolerability rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Measurement of impedances and extracellular water (ECW) ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of new HO lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and severity of treatment-emergent adverse events of special interest (AESIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Loading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of myocardial infarction, ischemic stroke, arterial revascularization, and all-cause death
Endpoint domain: Mortality/survival
Primary endpoint: Fever Incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Objective response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Hematological improvement
Primary endpoint: Parent Fidelity of Pivotal Response Treatment Implementation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child Functional Verbal Utterances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-treatment urine output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes